Evidence map›Paper›PMID 41533173›Full record

ArticleMolecular biology reports2026

Disorders of sex development associated with MPI and RSPH1 variants expand the phenotypic spectrum of CDG and PCD in Morocco.

Houda Harmak, Salaheddine Redouane, Adil El Hamouchi, Hicham Charoute, Ouafaa Aniq Filali, Rachid Aboutaieb, Abdelhamid Barakat, Hassan Rouba

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Houda HarmakLaboratory of Genomics and Human Genetics, Institut Pasteur du Maroc, Casablanca, 20360, Morocco. harmakhouda1997@gmail.com.ORCID http://orcid.org/0000-0002-5252-0257
Salaheddine RedouaneLaboratory of Genomics and Human Genetics, Institut Pasteur du Maroc, Casablanca, 20360, Morocco.
Adil El HamouchiLaboratory of Genomics and Human Genetics, Institut Pasteur du Maroc, Casablanca, 20360, Morocco.
Hicham CharouteLaboratoire de Séquençage Génomique, Institut Pasteur du Maroc, Casablanca, 20360, Morocco.
Ouafaa Aniq FilaliLaboratory of Physiopathology, Molecular Genetics and Biotechnology, Department of Biology, Faculty of Sciences Ain Chock, Hassan II University, Casablanca, Morocco.
Rachid AboutaiebLaboratory of Sexual and Reproductive Health, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, 20360, Morocco.
Abdelhamid Barakat *Laboratory of Genomics and Human Genetics, Institut Pasteur du Maroc, Casablanca, 20360, Morocco.
Hassan Rouba *Laboratory of Genomics and Human Genetics, Institut Pasteur du Maroc, Casablanca, 20360, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman sex development is a highly regulated process guiding undifferentiated gonads toward a testicular or ovarian fate. Disruptions in this pathway result in disorders of sexual development (DSD), characterized by atypical chromosomal, gonadal, or anatomical sex. These conditions usually appear as ambiguous genitalia at birth or as atypical pubertal development during adolescence. Different etiologic, phenotypic, and genotypic factors can cause DSD. Advances in next-generation sequencing (NGS) have significantly accelerated the identification of genetic variants through targeted panels, including both known genes involved in sex determination and differentiation, as well as newly discovered genes linked to DSD. METHODS AND

resultsIn this study, whole exome sequencing (WES) was performed on a Moroccan patient, born to non-consanguineous parents, who presented with severe hypospadias, micropenis, and cryptorchidism, and exhibited overlapping phenotypic features consistent with congenital disorder of glycosylation (CDG) and primary ciliary dyskinesia (PCD). After variant annotation and prioritization, two heterozygous variants in the MPI (c.305 C > T; p. Ser102Leu) and RSPH1 (c.471 C > G; p. His157Gln) genes were identified and confirmed by Sanger sequencing in family members. Their pathogenic effects on protein structures and functions were subsequently anticipated using bioinformatic tools and molecular dynamics (MD) simulations.

conclusionsTo our knowledge, this is the first report of these specific variants in the context of DSD, shedding light on a unique genotype-phenotype profile associated with the patient's complex clinical presentation. The high genetic variability underlying these disorders has made molecular diagnosis challenging. Yet, genomic approaches could expand our understanding of DSD landscape and improve diagnosis, personalized interventions, and patient management.

Indexed as

Congenital Disorders of GlycosylationDisorders of Sex DevelopmentExome SequencingFemaleHumansMaleMoroccoMutationPedigreePhenotypeSexual DevelopmentCongenital disorder of glycosylation (CDG)Disorders of sexual development (DSD)Molecular dynamics (MD)Moroccan patientMPIPrimary ciliary dyskinesia (PCD)RSPH1Whole exome sequencing (WES)

Identifiers

PMID41533173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.